FDA Inspection 1237404 — Arizona Center For Reproductive Endocrinology & Infertility
The FDA completed an inspection of Arizona Center For Reproductive Endocrinology & Infertility on Jun 12, 2024 in Tucson, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 12, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Tucson, AZ (United States)